Identifying optimal first-line interventions for advanced non-small cell lung carcinoma according to PD-L1 expression: a systematic review and network meta-analysis

Identifying optimal first-line interventions for advanced non-small cell lung carcinoma according to PD-L1 expression: a systematic review and network meta-analysis

This network meta-analysis (NMA), based on one phase II and nine phase III studies, involving 6,124 patients with metastatic NSCLC, indirectly compares Atezolizumab + Bevacizumab + chemotherapy (ABC), Atezolizumab + chemotherapy (AC), Pembrolizumab + chemotherapy (PC), Pembrolizumab alone, Bevacizum...

Full description

Bibliographic Details
Main Authors: Jie Liu, Chengming Li, Samuel Seery, Jinming Yu, Xue Meng
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:OncoImmunology
Subjects:
non-small-cell-lung-carcinoma
cancer
pd-l1
expression
adverse events
survival
combined
interventions
systematic review
network meta-analysis
Online Access:http://dx.doi.org/10.1080/2162402X.2020.1746112

Internet

http://dx.doi.org/10.1080/2162402X.2020.1746112

Similar Items